ALLR — Allarity Therapeutics Inc · P/E 0.0, rev $25.0K

Allarity Therapeutics Inc (ALLR) is a biotechnology company listed on US.

Latest reported ALLR revenue for 2026-06-30 was $25.0K. Net income was -$6.2M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. ALLR currently screens at market cap $15.1M and trailing P/E 0.0.

Use this ALLR page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ALLR quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ALLR SEC filings page. Lician reads the product cache first so this HTML stays unique to Allarity Therapeutics Inc even when a live quote feed is slow.

Allarity Therapeutics Inc latest statements (FY2025)

Latest cached year on this hub. Full ALLR income, balance, and cash tables.

  • Revenue$320.0K
  • Net Income-$11.2M
  • Total Assets$18.3M
  • Total Debt$0
  • Free Cash Flow-$14.8M

ALLR recent filings